NAS:GLMD (Israel)  
Galmed Pharmaceuticals Ltd logo

Galmed Pharmaceuticals Ltd

$ 0.34 +0.0099 (+3.01%) 02:27 PM EST
P/E:
At Loss
P/B:
0.41
Market Cap:
$ 8.51M
Enterprise V:
$ -14.01M
Volume:
9.74K
Avg Vol (2M):
75.56K
Also Trade In:
Volume:
9.74K
Market Cap $:
8.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
75.56K
Enterprise Value $:
-14.01M
PB Ratio:
0.41
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Name Current Vs Industry Vs History
Cash-To-Debt 167.18
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.06
9-Day RSI 33.55
14-Day RSI 33.91
6-1 Month Momentum % -72.73
12-1 Month Momentum % -83.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.48
Quick Ratio 8.48
Cash Ratio 8.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.1

Financials (Next Earnings Date:2022-11-08 Est.)

GLMD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GLMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1
Beta 0.97
Volatility % 84.76
14-Day RSI 33.91
14-Day ATR ($) 0.035759
20-Day SMA ($) 0.386654
12-1 Month Momentum % -83.52
52-Week Range ($) 0.3 - 3.13
Shares Outstanding (Mil) 25.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galmed Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

Galmed Pharmaceuticals Ltd Analysis

Share your research

Headlines

See More
No news.